• Devices
    • Medical Remanufacturing
    • Catalogue
    • Electrophysiology
      • CARTO3
      • EnSite Precision
    • Surgical Instruments
      • Harmonic
    • Purchase of used medical devices
    • eIFU
  • About us
    • Sustainability
    • Economy
    • Safety
    • AMDR
  • Career
  • News
  • Downloads
    • eIFU
  • Contact
  • LogIn
  • English
    • Deutsch
    • English
    • Español
    • Nederlands
    • Français
    • Svenska
    • Dansk
    • Português
    • Norsk Bokmål
Remanufacturing First, Then Recycling: How Hospitals Can Keep Medical Devices in the Circular Economy

Remanufacturing First, Then Recycling: How Hospitals Can Keep Medical Devices in the Circular Economy

by Clemens Köhler | 28. April 2026 | News (en)

In short: remanufacturing first, then recycling. What this means in practice can be seen in everyday hospital operations. At Marien Gesellschaft Siegen, a hospital group in North Rhine-Westphalia, a total of 2,938 remanufactured medical devices from the product groups...
Four perspectives, one shared goal: introducing our Executive Support Team

Four perspectives, one shared goal: introducing our Executive Support Team

by Clemens Köhler | 16. April 2026 | News (en)

What unites the team? A clear service mindset, pace and the ambition to give purpose to work at Vanguard: making sustainable medical technology understandable and actively shaping change in healthcare. Jana Icke – Head of Executive Support Team (focus on Operations)...
Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice

Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice

by Clemens Köhler | 11. March 2026 | News (en)

CE remanufacturing: remanufacturing with manufacturer responsibility In CE remanufacturing, the medical device originally labelled as single-use becomes the property of Vanguard and is subsequently restored through a validated remanufacturing process. In accordance...
TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG

TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG

by MarketingVanguard | 23. February 2026 | News (en)

CE reprocessing of single-use devices means that Vanguard assumes full responsibility as a medical device manufacturer under the MDR. This includes technical documentation, clinical evaluation, post-market surveillance and vigilance. The certification process was...
Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701

Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701

by Clemens Köhler | 11. February 2026 | News (en)

A total of 36 woody vegetation strips have been established across the arable field. These are divided into three row types: sweet chestnut, fodder trees and standard fruit trees. Within these strips, 55 different woody and herbaceous species have been introduced,...
Why We Need to Talk About “Scope 4” and the Contribution Remanufacturing Can Make

Why We Need to Talk About “Scope 4” and the Contribution Remanufacturing Can Make

by Clemens Köhler | 27. January 2026 | News (en)

A Missing Element in the Emissions Framework: The Concept of Scope 4 Scope 4 describes exactly what is missing from the current system: the avoidance of emissions through reuse, repair, or remanufacturing. While Scopes 1–3 measure what companies generate, Scope 4...
« Older Entries

Recent Posts

  • Remanufacturing First, Then Recycling: How Hospitals Can Keep Medical Devices in the Circular Economy
  • Four perspectives, one shared goal: introducing our Executive Support Team
  • Hygienic, safe, compliant: CE, CS and KRINKO in remanufacturing practice
  • TÜV NORD Awards First MDR Certificate for CE Reprocessing to Vanguard AG
  • Agroforestry Project Update: A Diverse Ecosystem Is Taking Shape on Field 701

Recent Comments

No comments to show.

Vanguard AG
Landsberger Str. 222
12623 Berlin
Deutschland
Kundenservice: 030 - 318 73 43 - 300

Vanguard Medical Devices Limited
The Scalpel, 18th Floor, 52 Lime Street
London EC3M 7AF
UK

International customer service:
+49 30 - 318 73 43 - 300

© 2026 Vanguard AG. All rights reserved.

Impressum   Datenschutzerklärung   AGB   Kontakt   Datenschutzhinweise für Aktionäre